Covered recipient · General Payments record
SHANNA L WILKES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2023
$1,867.31
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $547.40 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $168.29 | 6 |
| Abbott Laboratories | $142.79 | 1 |
| CVRx Inc. | $109.95 | 1 |
| Janssen Pharmaceuticals, Inc | $38.67 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.02 | 1 |
| PFIZER INC. | $18.09 | 1 |
| GlaxoSmithKline, LLC. | $16.93 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.44 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $142.79 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017809229 | CMS |
| Amgen Inc. | $16.23 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020498817 | CMS |
| Amgen Inc. | $6.30 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020498821 | CMS |
| Amgen Inc. | $109.90 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020498833 | CMS |
| Amgen Inc. | $11.39 | 07/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020498825 | CMS |
| Amgen Inc. | $10.18 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020498829 | CMS |
| Amgen Inc. | $14.29 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020498837 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.02 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996827811 | CMS |
| CVRx, Inc. | $109.95 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1058739981 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.44 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015033591 | CMS |
| GlaxoSmithKline, LLC. | $16.93 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004351817 | CMS |
| Janssen Pharmaceuticals, Inc | $18.94 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987961169 | CMS |
| Janssen Pharmaceuticals, Inc | $19.73 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987961159 | CMS |
| Novartis Pharmaceuticals Corporation | $14.22 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993308877 | CMS |
| PFIZER INC. | $18.09 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049566323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.